What is the market opportunity for infectious disease diagnostic tests. How will revenue opportunity for test sales grow next four or five years? In what geographies will the revenues be earned? Who are the company leaders, and what recent trends are experts noticing that market watchers can take note of? These are among the questions addressed at an upcoming webinar you can be part of.
A recurring theme in recent Eye on IVD newsletters is the significant potential across various in vitro diagnostic submarkets. Among these, the infectious disease sector stands out as a particularly stable and growing opportunity. Emerging diseases pose ongoing challenges to optimal healthcare, ensuring sustained demand for innovative companies in this space. While some markets have matured, many remain maturation-resistant. This is due to the constant evolution of infections and the emergence of new pathogens. Global trends such as increased globalization, climate change, population growth, and aging populations continue to drive demand for microbiology-related in vitro diagnostic products.
Join us for our next webinar, highlighting the opportunity in Infectious Disease. After attending the Infectious Disease IVD Market Opportunity and Trends, one will learn the following:
- Size of the Infectious Disease Market and Growth to 2028
- Historic Size of Market Opportunity from 2019 and 2021
- Panel Test and Point of Care Trends
- Eye on IVD’s 3 Disease Areas of Maximum Interest
- Eye on IVD’s 3 Top Geographies of Interest
- Eye on IVD’s 3 Companies to Watch
The webinar will last 25 minutes, with 5 minutes for Q&A as time allows. All the information in the webinar is based on the Eye On IVD market report, Infectious Disease IVD Market Review Report, published in 2024 by Eye On IVD, LLC.
